Idorsia surges after FDA approves co's hypertension drug

Idorsia

20/03/2024 07:38

** Idorsia's  IDIA.S  shares jump 25% in pre-market trade
following the FDA approval of the Swiss drugmaker's hypertension
drug Tryvio
    ** The FDA approved Tryvio for the treatment of hypertension
in combination with other antihypertensive drugs, to lower blood
pressure in adult patients who are not adequately controlled on
other drugs, Idorsia said
        ** "We view the approval as a positive," J.P.Morgan says
in a note
  
        ** It adds, however, that it sees the focus shifting to
whether Idorsia is able to sell the now more de-risked product
to generate cash, after Johnson & Johnson  JNJ.N  returned
rights to the asset in September 2023
  


 (Reporting by Tristan Veyet)
 ((Tristan.chabba@thomsonreuters.com))